Membrane-destabilizing ionizable phospholipids for organ-selective mRNA delivery and CRISPR-Cas gene editing
By acting as a pioneer in new markets and developing innovative products, we are aiming to grow as a company that fulfills its responsibilities in the global health sector. by Joo-kyung Cha ([email protected])
He is a member of the Australasian Society of Cosmetic Medicine and has been a qualified cosmetic practitioner for over 37 years
Curran EM, Judy BM, Newton LG, Lubahn DB, Rottinghaus GE, et al
The glucagon-like peptide-1 agonists (GLP-1s) class of weight-loss drugs, which includes medications like tirzepatide and semaglutide, have been shown to reduce body fat in large clinical trials
Glutatyonun damar yolu ile alnmas sayesinde direkt bir ekilde kana karmaktadr